Science
BNGO! Looks Like Bionano Genomics Could Be a Winner
Here's why the current weakness in Bionano Genomics could be a buying opportunity.
Intellia Therapeutics Busts Out of Resistance on Positive Trial News
The news sent shares of the genome editing company skyward after the stock had been basing for months.
Halfway Home and This Portfolio of Lovable Losers Keeps Delivering
The 2021 Tax Loss Selling Recovery Portfolio didn't do much in April but is soundly beating the market six months after inception.
CRISPR Therapeutics Could Suffer Further Steep Losses
Let's look over the charts and indicators.
If You're Buying Bionano Genomics Know That It's Speculative Only
I have a problem with stocks that trade for pennies one day and then soar higher the next.
Look for the Rally in Charles River Labs to Continue
Here's how traders can play shares of the contract research company.
Jim Cramer: What's Winning Is the Technology of Replacement
If you look at the economy as between service and tech you find the old-guard being overrun.
Acceleron Pharma Looks Poised to Continue Bull Run in 2021
The biopharma company's stock has built a nice base, which suggests the shares could keep moving significantly higher in the coming months.
Watch Out, Pacific Biosciences Stock Is Very Extended
This candlestick pattern is very successful in catching significant tops.
Thankful for Life, Sloppy Wednesday, Sizing Up Salesforce, Keep on Fighting
The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.